×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Apollo Medical Stock Forecast, Price & News

$38.61
+0.02 (+0.05%)
(As of 07/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$37.40
$39.50
50-Day Range
$30.56
$40.85
52-Week Range
$29.52
$133.23
Volume
262,889 shs
Average Volume
267,392 shs
Market Capitalization
$2.16 billion
P/E Ratio
23.69
Dividend Yield
N/A
Price Target
$92.00

Apollo Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
138.3% Upside
$92.00 Price Target
Short Interest
Bearish
19.39% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.63
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$9.25 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.51 out of 5 stars

Medical Sector

91st out of 1,412 stocks

Management Consulting Services Industry

3rd out of 26 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive AMEH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter.

Apollo Medical logo

About Apollo Medical (NASDAQ:AMEH) Stock

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.

AMEH Stock News Headlines

Apollo Medical (NASDAQ:AMEH) Shares Gap Down to $35.80
Apollo Medical Hlgs: Q4 Earnings Insights
Apollo Medical Holdings (AMEH)
MODV or AMEH: Which Is the Better Value Stock Right Now?
See More Headlines

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AMEH
Employees
1,133
Year Founded
N/A

Company Calendar

Last Earnings
5/05/2022
Today
7/03/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$92.00
High Stock Price Forecast
$92.00
Low Stock Price Forecast
$92.00
Forecasted Upside/Downside
+138.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.5
Research Coverage
2 Analysts

Profitability

Net Income
$73.86 million
Pretax Margin
8.68%

Debt

Sales & Book Value

Annual Sales
$773.91 million
Cash Flow
$1.66 per share
Book Value
$8.29 per share

Miscellaneous

Free Float
49,133,000
Market Cap
$2.16 billion
Optionable
Not Optionable
Beta
0.52














Apollo Medical Frequently Asked Questions

Should I buy or sell Apollo Medical stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" Apollo Medical stock.
View analyst ratings for Apollo Medical
or view top-rated stocks.

What is Apollo Medical's stock price forecast for 2022?

2 Wall Street analysts have issued 12 month target prices for Apollo Medical's stock. Their AMEH stock forecasts range from $92.00 to $92.00. On average, they expect Apollo Medical's share price to reach $92.00 in the next year. This suggests a possible upside of 138.3% from the stock's current price.
View analysts' price targets for Apollo Medical
or view top-rated stocks among Wall Street analysts.

How has Apollo Medical's stock performed in 2022?

Apollo Medical's stock was trading at $73.48 at the beginning of the year. Since then, AMEH stock has decreased by 47.5% and is now trading at $38.61.
View the best growth stocks for 2022 here
.

When is Apollo Medical's next earnings date?

Apollo Medical is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Apollo Medical
.

How were Apollo Medical's earnings last quarter?

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) posted its quarterly earnings data on Thursday, May, 5th. The company reported $0.31 EPS for the quarter. The firm had revenue of $263.26 million for the quarter. Apollo Medical had a trailing twelve-month return on equity of 16.80% and a net margin of 8.71%.
View Apollo Medical's earnings history
.

What guidance has Apollo Medical issued on next quarter's earnings?

Apollo Medical updated its FY 2022 earnings guidance on Monday, May, 30th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.05 billion-$1.08 billion, compared to the consensus revenue estimate of $1.05 billion.

Who are Apollo Medical's key executives?

Apollo Medical's management team includes the following people:
  • Dr. Kenneth T. Sim M.D., Exec. Chairman (Age 68, Pay $1.09M)
  • Dr. Thomas S. Lam M.D., M.P.H., Pres, Co-CEO & Director (Age 73, Pay $1.08M)
  • Mr. Brandon Sim, Co-Chief Exec. Officer (Age 28, Pay $1.04M) (LinkedIn Profile)
  • Dr. WaiChow Young M.D., Chief Admin. Officer (Age 75, Pay $453.73k)
  • Mr. Chan Basho, Chief Strategy Officer & Interim CFO
  • Dr. Jeremy R. Jackson M.D., Chief Quality Officer
  • Mr. Neil Ahuja, Pres of Provider Solutions
  • Yubin Park, Chief Analytics Officer

What is Thomas Lam's approval rating as Apollo Medical's CEO?

9 employees have rated Apollo Medical CEO Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among Apollo Medical's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Apollo Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Square (SQ) and Exxon Mobil (XOM).

What is Apollo Medical's stock symbol?

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

How do I buy shares of Apollo Medical?

Shares of AMEH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Apollo Medical's stock price today?

One share of AMEH stock can currently be purchased for approximately $38.61.

How much money does Apollo Medical make?

Apollo Medical (NASDAQ:AMEH) has a market capitalization of $2.16 billion and generates $773.91 million in revenue each year. The company earns $73.86 million in net income (profit) each year or $1.629990 on an earnings per share basis.

How many employees does Apollo Medical have?

Apollo Medical employs 1,133 workers across the globe.

How can I contact Apollo Medical?

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The official website for Apollo Medical is www.apollomed.net. The company can be reached via phone at (626) 943-6491, via email at investors@apollomed.net, or via fax at 818-839-5190.

This page (NASDAQ:AMEH) was last updated on 7/3/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.